Clinical trials: Fellow
Inherited Retinal Dystrophy
Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy
Up to nine subjects who have participated in the earlier LX101 clinical study, and who meet all study eligibility criteria, will receive LX101 administration in the previously uninjected, contralateral eye to evaluate the safety…
- Trial name
- NCT06212297
- Testing
- LX101
- Where
- China
- Volunteers
- 9 people
- Sponsor
- Innostellar Biotherapeutics Co.,Ltd